Thomas John Dietz Insider Profile
4 Followers
Thomas John Dietz, Director at Paratek Pharmaceuticals, holds 152.50K shares in Cypherpunk Technologies (Ticker: CYPH), holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds 71.00K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ).
Thomas John Dietz Paratek Pharmaceuticals (PRTK)Director
Paratek Pharmaceuticals (PRTK)
Director
Ranked #72,552 out of 106,487 Corporate Insiders
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
-7.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas John Dietz's holdings
Insider Roles
Director
Roles that Thomas John Dietz holds in companies
Most Profitable Insider Trade
Stock:
Eiger Biopharmaceuticals
(EIGRQ)
(EIGRQ)
Rating:Informative Buy
Date:Mar 17, 2020 - Mar 17, 2021
Return:+82.70%
The most profitable trade made by Thomas John Dietz
Thomas John Dietz's Trading History
Paratek Pharmaceuticals
Sep 21, 2023
―
Uninformative Sell
―
$0.00
Eiger Biopharmaceuticals
Jan 25, 2023
―
Informative Buy
71.50K
$603.50K
Cypherpunk Technologies
Mar 17, 2026
Director
Uninformative Buy
60.61K
$152.35K
List of latest transactions for each holding click on a transaction to see Thomas John Dietz's performance on stock
You May Also Like
Thomas John Dietz insider profile FAQ
What is the percentage of profitable transactions made by Thomas John Dietz?
The percentage of profitable transactions made by Thomas John Dietz is 40%.
What is the average return per transaction made by Thomas John Dietz?
The average return per transaction made by Thomas John Dietz is -7.10%.
What stocks does Thomas John Dietz hold?
Thomas John Dietz holds: PRTK, EIGRQ, CYPH stocks.
What was Thomas John Dietz’s latest transaction?
Thomas John Dietz latest transaction was an Uninformative Buy of $60.61K.
What was Thomas John Dietz's most profitable transaction?
Thomas John Dietz’s most profitable transaction was an Informative Buy of EIGRQ stock on March 17, 2020. The return on the trade was 82.70%.
What is Thomas John Dietz's role in Paratek Pharmaceuticals?
Thomas John Dietz's role in Paratek Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.